NF- κ B and chemoresistance: potentiation of cancer drugs via inhibition of NF- κ B
- 1 August 1999
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 2 (4), 271-273
- https://doi.org/10.1054/drup.1999.0094
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell SurvivalScience, 1998
- Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced ApoptosisThe Journal of Experimental Medicine, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- Suppression of TNF-α-Induced Apoptosis by NF-κBScience, 1996
- TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κBScience, 1996
- TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBαImmunity, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κBNature, 1995